Derivados de indol como inhibidores de ras en el tratamiento del cancer

La descripción caracteriza compuestos macrocíclicos y composiciones farmacéuticas y sus complejos proteicos, capaces de inhibir proteínas Ras y sus usos en el tratamiento de cánceres. The disclosure features macrocyclic compounds, and pharmaceutical compositions and protein complexes thereof, capabl...

Full description

Saved in:
Bibliographic Details
Main Authors KOLTUN, Elena, S, SINGH, Mallika, BURNETT, G., Leslie, KNOX, John, E, AAY, Naing, WILDES, David, E, LEE, Bianca, Jennifer, GILL, Adrian, L, BUCKL, Andreas, LIU, Yang, CREGG, James, RICE, Meghan, A
Format Patent
LanguageSpanish
Published 29.09.2023
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:La descripción caracteriza compuestos macrocíclicos y composiciones farmacéuticas y sus complejos proteicos, capaces de inhibir proteínas Ras y sus usos en el tratamiento de cánceres. The disclosure features macrocyclic compounds, and pharmaceutical compositions and protein complexes thereof, capable of inhibiting Ras proteins, and their uses in the treatment of cancers.
Bibliography:Application Number: CL20230000730